ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Liver Transplants for Alcoholic Hepatitis Up During COVID-19 Pandemic
November 04, 2021Waiting-list registrations and liver transplants for alcoholic hepatitis (AH) have increased, exceeding the forecasted volumes, in association with increasing retail alcohol sales during the COVID-19 pandemic... -
First Patient Dosed in DUR-928 Study for Severe Alcohol-Associated Hepatitis
January 29, 2021DURECT has dosed the first patient in its AHFIRM randomized, double-blind, placebo-controlled, multi-center Phase 2b study to evaluate the safety and efficacy of DUR-928 in severe alcohol-associated hepatitis (AH) patients.
Pharma Sources Insight January 2025
